Department of Toxicology, School of Public Health, Xinxiang Medical University, Henan, China.
HanLingMedical Technology Research Institute Co., China.
J Med Food. 2023 Feb;26(2):81-92. doi: 10.1089/jmf.2022.K.0118. Epub 2023 Feb 2.
Red chili pepper is a beneficial natural spicy food that has antiobesity and antitype II diabetes effects, but it is not conducive to in-depth research as a dietary strategy to treat obesity. This study aims to investigate the beneficial effects of red chili pepper, fermented with a novel RPG-HL-0136. LC-MS/MS analysis is conducted to detect the content of capsaicin and dihydrocapsaicin, and no significant difference is observed between the nonfermented red chili pepper (NFP) (W/W) and the prepared RPG-HL-0136fermented chili mixture (LFP). After establishing a high-fat diet-induced obese type II diabetic mouse model, the effects on weight gain, weight loss of liver and testicular fat, total cholesterol, triglyceride, fasting glucose, insulin, and homeostatic model assessment for insulin resistance in LFP were evaluated to be better than those in NFP following 10 weeks of interventions. All animal experiments were approved by the Institutional Animal Care and Use Committee of Xinxiang medical university. NFP and LFP could increase the expression of transient receptor potential vanilloid subfamily 1, peroxisome proliferator-activated receptor-alpha and caspase-2 in the high-fat mice. Compared with unfermented red chili pepper, the fermented red chili pepper complex significantly reduced LPS, tumor necrosis factor-alpha, and interleukin-6 in serum ( < .05). Intake of LFP significantly increased the expression of claudin-1 and occludin in the colon of the high-fat mice ( < .05), and there was no damage to the stomach and colon. This study provides scientific evidence that red chili pepper, fermented with RPG-HL-0136, may be beneficial for future treatment of obesity and accompanying diabetes. (IACUC.No.XYLL-20200019).
红辣椒是一种有益的天然辛辣食品,具有抗肥胖和抗 2 型糖尿病的作用,但作为一种治疗肥胖的饮食策略,不利于深入研究。本研究旨在探讨红辣椒经新型 RPG-HL-0136 发酵后的有益作用。采用 LC-MS/MS 分析检测辣椒素和二氢辣椒素的含量,发现未发酵红辣椒(NFP)(W/W)和制备的 RPG-HL-0136 发酵辣椒混合物(LFP)之间没有显著差异。在建立高脂肪饮食诱导的肥胖 2 型糖尿病小鼠模型后,评估 LFP 对体重增加、肝脏和睾丸脂肪重量减轻、总胆固醇、甘油三酯、空腹血糖、胰岛素和胰岛素抵抗稳态模型评估的影响,发现干预 10 周后 LFP 的效果优于 NFP。所有动物实验均获得新乡医学院机构动物护理和使用委员会的批准。NFP 和 LFP 可增加高脂肪小鼠中瞬时受体电位香草酸亚型 1、过氧化物酶体增殖物激活受体-α和半胱天冬酶-2 的表达。与未发酵的红辣椒相比,发酵的红辣椒复合物显著降低了血清中的脂多糖、肿瘤坏死因子-α和白细胞介素-6( < .05)。摄入 LFP 可显著增加高脂肪小鼠结肠中 Claudin-1 和 Occludin 的表达( < .05),且对胃和结肠没有损伤。本研究为红辣椒经 RPG-HL-0136 发酵可能有益于未来肥胖及其伴随的糖尿病治疗提供了科学依据。(IACUC.No.XYLL-20200019)。